ORGAN-TRANSPLANT recipients are prone to the development of cutaneous and extracutaneous malignant tumors.1 , 2 Lymphomas occur in 1 to 2 percent of graft recipients and are usually of the B-cell type.3 Cutaneous T-cell lymphomas are extremely rare. We describe a renal-transplant recipient with multiple cutaneous warts and squamous-cell carcinomas in whom a cutaneous T-cell lymphoma (Sezary syndrome) later developed, followed by a nodal B-cell lymphoma with immunoblastic components. Despite chemotherapy, the cutaneous T-cell lymphoma progressed rapidly, and the patient died within a year of the diagnosis. This case illustrates the role of immunosuppression in the development of multiple and complex malignant . . .
No takes yet. Share an insight, caveat, or question.
Euvrard et al. (1992) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: